Adaptimmune Therapeutics Plc - ADR Shares Fall 1.5% Below Previous 52-Week Low - Market Mover
The shares fell 1.5% lower than its previous 52-week low of $3.35, with trading volume lower than its 30 day average
Jan 15, 2022 by Kwhen Finance Editors
Adaptimmune Therapeutics Plc - ADR (ADAP) shares closed 1.5% lower than its previous 52 week low, giving the company a market cap of $524M. The stock is currently down 10.4% year-to-date, down 42.3% over the past 12 months, and down 25.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%.
Trading Activity
- Trading volume this week was 29.2% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
- The stock closed at 3.7% lower than its 5-day moving average, 11.8% lower than its 20-day moving average, and 28.6% lower than its 90-day moving average.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Adaptimmune Therapeutics Plc - ADR | -1.8 | -10.4 | -42.3 | -54.4 | 0.0 |
| Dow Jones Industrial Average | -0.6 | -0.6 | 18.2 | -3.1 | 22.0 |
| S&P 500 Index | 0.0 | -2.2 | 23.9 | -3.9 | 26.9 |
| Technology Industry | 7.7 | 16.9 | -62.2 | -64.1 | 26.0 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 41.0%
- The company's stock price performance over the past 12 months lags the peer average by 129.1%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics Plc - ADR | ADAP | 0 | -10.4 | -42.3 | -54.4 | 0 |
| Peer Avg | N/A | 14.8 | -7.4 | -18.5 | -46.6 | 8.1 |
| Novavax, Inc. | NVAX | -7.9 | -21.5 | -11.0 | -69.5 | -9.0 |
| Exelixis Inc | EXEL | 34.2 | -2.8 | -27.1 | -31.2 | 14.4 |
| uniQure N.V. | QURE | 2.8 | -6.5 | -49.0 | -52.5 | 2.8 |
| Enzo Biochem, Inc. | ENZ | 30.0 | 1.2 | 13.2 | -33.2 | 24.1 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: